Picato (ingenol mebutate) – Suspension of the marketing authorisation due to risk of skin malignancy
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
|Therapeutic area (MeSH)||
|Human ATC code||